Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Astrazeneca Plc Ord (AZNCF)
Astrazeneca Plc Ord (AZNCF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow 11.80
  • Price/Book 4.44
Trade AZNCF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
130.0800 +6.03%
on 09/13/23
139.8800 -1.39%
on 08/30/23
+2.1300 (+1.57%)
since 08/22/23
3-Month
127.7500 +7.97%
on 07/07/23
146.5500 -5.88%
on 06/23/23
-8.7500 (-5.97%)
since 06/22/23
52-Week
104.5000 +31.99%
on 09/26/22
153.1000 -9.91%
on 04/24/23
+26.3300 (+23.59%)
since 09/22/22

Most Recent Stories

More News
Schrodinger is an AI-Powered Drug Discovery Developer to Watch

Drug discovery software developer Schrodinger Inc. (NASDAQ: SDGR) stock has been trying to recover after plummeting over 80% off its all-time high of $117

SDGR : 29.03 (-2.35%)
AZN.LN : 11,046.001 (+1.47%)
AZN : 67.83 (+1.21%)
AZNCF : 137.9300 (+2.97%)
LLY : 550.54 (+0.07%)
GSK : 37.43 (-0.51%)
GSK.LN : 1,527.800 (-0.18%)
ON : 93.81 (+3.17%)
PFE : 32.69 (-0.49%)
MRK : 106.34 (-0.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 137.9300
2nd Resistance Point 137.9300
1st Resistance Point 137.9300
Last Price 137.9300
1st Support Level 137.9300
2nd Support Level 137.9300
3rd Support Level 137.9300

See More

52-Week High 153.1000
Last Price 137.9300
Fibonacci 61.8% 134.5348
Fibonacci 50% 128.8000
Fibonacci 38.2% 123.0652
52-Week Low 104.5000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar